Bartlett R J, Pericak-Vance M A, Koh J, Yamaoka L H, Chen J C, Hung W Y, Speer M C, Wapenaar M C, Van Ommen G J, Bakker E
Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Neurology. 1988 Jan;38(1):1-4. doi: 10.1212/wnl.38.1.1.
DNA probes are available for Duchenne muscular dystrophy (DMD) carrier detection and prenatal diagnosis. With probes for about 25% of the proximal portion of the gene, we found the proximal probes detected deletions in 23% of nonselected DMD boys, while a single distal probe detected 17% more as deletions. The combined percentage was 39% for all probes tested. Prenatal diagnosis and carrier detection are more accurate if deletions are mapped rather than by use of restriction fragment length polymorphism analysis. The effort involved in screening all affected boys for deletions is considerably less, and provides an accurate genetic marker for subsequent prenatal diagnosis in the family and prospective counseling for female relatives. It seems likely that, once the entire gene (cDNA) is available for screening, most DMD boys will show deletions.
DNA探针可用于杜氏肌营养不良症(DMD)携带者检测和产前诊断。使用针对该基因约25%近端部分的探针,我们发现近端探针在23%未经选择的DMD男孩中检测到缺失,而单个远端探针检测到的缺失多17%。所有测试探针的综合百分比为39%。如果对缺失进行定位,而不是使用限制性片段长度多态性分析,产前诊断和携带者检测会更准确。筛查所有受影响男孩的缺失所涉及的工作量要少得多,并为该家庭随后的产前诊断提供准确的遗传标记,以及为女性亲属提供前瞻性咨询。一旦整个基因(cDNA)可用于筛查,大多数DMD男孩似乎会显示出缺失。